首页 正文

Long-term response in a patient with adenocarcinoma harboring both common and uncommon EGFR mutations

{{output}}
Recently, we read a paper "Dacomitinib overcomes afatinib-refractory carcinomatous meningitis in a lung cancer patient harbouring EGFR Ex.19 deletion and G724S mutation" published in Investigational New Drugs. Their patient had a very rare compound EGFR mutati... ...